Google          

HOME    Introduction    Publish    CopyRights   about us      首页HOME    中文首页

Formal     Natural    Applied   Life science    Healthcare    Social    Interdisciplinary 

 
                          

 

Intercultural Perspectives on the Complementary Application and Evidence-Based Research of Chinese and Western Herbal Medicine in Geriatric Healthcare  

Charles Cheng Xia     xc7788@gmail.com

Abstract

The acceleration of global population aging has intensified the clinical challenges of multimorbidity and age-associated chronic low-grade inflammation ("inflammaging"). Traditional western polypharmacy in elderly patients frequently precipitates hepatorenal toxicity, metabolic deceleration, and drug accumulation. From an intercultural perspective, this study systematically investigates the complementary applications of Traditional Chinese Medicine (TCM) and Western Herbalism in geriatric healthcare. Through a molecular pharmacological dissection of five core natural agents—Astragalus membranaceus, Ganoderma lucidum, Panax quinquefolius, Quercetin, and Grape Seed Extract—this paper elucidates the scientific convergence of Chinese "Zheng-strengthening" (tonifying vital energy) and Western "adaptogenic/polyphenolic antioxidation" theories. These convergence vectors are validated across the neuroendocrine-immune (NEI) regulatory network, telomerase activation, senolytic clearance, and the modulation of the Nrf2 and NF-κB signaling pathways. Concurrently, the study rigorously evaluates the clinical risks of Herb-Drug Interactions (HDIs) at both pharmacokinetic levels (such as CYP3A4 inhibition by flavonoids) and pharmacodynamic levels (such as cumulative bleeding risks induced by combining antiplatelet western drugs with blood-activating Chinese herbs). Finally, this paper proposes proactive clinical risk-control strategies—including the construction of an integrated East-West macro-healthcare model, the development of intelligent HDI screening databases, and the enforcement of staggered-administration protocols—thereby providing robust evidence-based medical support for the future development and integration of natural botanical products within the international longevity industry.

Keywords: Aging; Chinese Herbal Medicine; Western Herbalism; Neuroendocrine-Immune Network (NEI); Herb-Drug Interactions (HDI); Evidence-Based Medicine


I. Introduction

1.1 Research Background: The Severe Challenges of Global Aging and Chronic Disease Management

Since the turn of the 21st century, global demographic structures have undergone a profound and unprecedented transformation, with population aging emerging as a monumental socio-medical challenge shared by nations worldwide. As human life expectancy extends, the focus of healthcare management for the elderly has shifted from acute infectious diseases toward the long-term management of complex, multi-system chronic and degenerative conditions. The physiological profile of geriatric patients is exceptionally distinct and complex, characterized primarily by "multimorbidity" and "inflammaging"—the age-associated, chronic, low-grade systemic inflammation. As organisms age, the immune system undergoes progressive dysregulation, lapsing into a chronic, non-specific micro-inflammatory state. This state serves as the shared pathophysiological substrate for an array of geriatric conditions, including Alzheimer’s disease, cardiovascular pathologies, type II diabetes, and osteoporosis.

However, contemporary biomedicine (Western medicine) often resorts to an antagonistic, single-target approach ("one disease, one drug") when managing these concurrent multi-system chronic ailments. This practice directly leads to "polypharmacy," an exceedingly pervasive phenomenon among the elderly. Clinical surveys indicate that geriatric patients suffering from multiple chronic diseases ingest an average of 5 to 10 distinct synthetic chemical pharmaceuticals daily. Compounding this issue, age-related physiological declines—such as a contraction in liver volume, diminished hepatic cytochrome P450 enzyme activity, and a lower glomerular filtration rate (GFR)—profoundly decelerate drug metabolism and clearance. Consequently, polypharmacy not only triggers severe drug accumulation and toxicity but also precipitates adverse reactions through intricate drug-drug interactions, resulting in drug-induced hepatorenal impairment and gastrointestinal mucosal barrier destruction. Therefore, exploring a gentler, safer, multi-target regulatory modality rooted in holistic principles has become an urgent imperative in modern geriatric medicine.

1.2 The Value of Intercultural Herbalism Research

Against this backdrop, herbal medicine, as the collective heritage of human medical civilizations, has re-emerged as a major focus of international academic interest due to its unique therapeutic and preventative attributes. Although Traditional Chinese Medicine (TCM) and Western Herbalism crystallized within distinct geographical environments and cultural paradigms, they share profound philosophical alignment regarding human aging and health preservation. The core tenets of TCM, "Fuzheng Guben" (strengthening the body’s resistance and consolidating its constitution) and the "Holistic Concept," emphasize restoring the systemic balance of Yin, Yang, Qi, and Blood to enhance intrinsic immunity. This methodology prioritizes "Zhi Wei Bing" (treating diseases before their onset), which entails intervening systemically before structural or irreversible pathology manifests. Symmetrically, Western Herbalism has historically operated under "Vitalism," which advocates utilizing the medicinal properties of plants to stimulate, support, and align with the body's innate self-healing capacity (Vis Medicatrix Naturae).

Placing Chinese and Western herbs within a unified academic framework for cross-cultural research is not a superficial aggregation of botanical ingredients; rather, it represents a deep functional synergy between two natural medical paradigms. Chinese herbal medicine excels in complex systemic differentiation (pattern identification) and formula composition (Fuxiang), allowing for precise adaptations to an individual’s dynamic physiological shifts. Conversely, Western Herbalism has amassed substantial modern evidence-based clinical and pharmacological data concerning the standardization of single-plant extracts, targeted receptor activities, and the rapid mitigation of specific physiological symptoms. This cross-cultural synthesis transcends the boundaries of either traditional system, delivering a diversified intervention model for "Healthy Ageing" that simultaneously balances macro-functional regulation with micro-scientific validation.

1.3 Research Objectives and Core Thesis Structure

This study aims to systematically map the theoretical intersections of Chinese and Western natural herbs within the field of geriatric healthcare. It deeply examines their clinical applications and molecular pharmacological mechanisms across four critical physiological pillars: the immune-endocrine, nervous, cardiovascular, and musculoskeletal systems. Concurrently, incorporating the latest findings from evidence-based medicine, this paper objectively evaluates the clinical safety challenges, Herb-Drug Interactions (HDIs), and cross-cultural formulation blind spots faced by the elderly in practical applications. Ultimately, this research seeks to furnish a solid theoretical foundation for the integrated R&D of natural botanical formulations in the global longevity industry and to offer actionable clinical safety guidelines for the concurrent administration of Chinese and Western herbs.


II. Theoretical Foundations and Scientific Confluences of East-West Geriatric Herbalism

2.1 Core Theories of Chinese Geriatric Healthcare: Kidney Essence Deficiency and "Zhi Wei Bing"

Traditional Chinese Medicine possesses a long history of understanding the mechanisms underlying human senescence. The classical expositions in the Huangdi Neijing (The Yellow Emperor's Inner Classic) regarding the progressive decline of bodily functions in females at "seven-seven" (49 years) and males at "eight-eight" (64 years) profoundly illustrate the immutable laws of biological aging. TCM posits that the fundamental pathological mechanism of geriatric senescence and multi-system chronic diseases resides in "Kidney Essence (Shenjing) Deficiency and Qi-Blood Dysregulation." In TCM theory, the Kidney is regarded as the "先天之本" (Root of Pre-natal Constitution), governing the bones, generating marrow, storing essence, and presiding over growth, development, and aging. As individuals enter senility, Kidney Qi naturally wanes and Kidney Essence becomes depleted, leading to an empty marrow sea (Suihai), brittle bones, and muscle atrophy. Because pre-natal essence fails to transform and generate sufficient post-natal Qi and Blood, a state of Qi deficiency arises. Lacking the vital impetus of Qi to propel blood circulation, "Qi stagnation and Blood stasis" ensue; conversely, Blood deficiency fails to nourish the viscera, causing a generalized operational decline across all organs. Therefore, the core principle of TCM in geriatric care centers on "Fuzheng Guben, Tiaoli Qixue"—nourishing true Yin and primordial Qi while invigorating blood circulation to delay degenerative organ pathologies.

Furthermore, the philosophy of "Zhi Wei Bing" (preventative treatment) is of decisive significance in geriatric care. The health status of the elderly is frequently balanced on a high-risk precipice of "sub-clinical" or "pre-morbid" states; although contemporary biochemical and physical indicators may hover within normal clinical thresholds, the organism’s internal equilibrium is severely compromised. By applying pattern differentiation and administering herbs accordingly, TCM does not fixate on the elimination of a single physical index. Instead, it rectifies the systemic balance of Yin and Yang, interrupting and reversing pathological trajectories before chronic conditions cause irreversible structural damage to the viscera. This approach aligns perfectly with the fragile physiological tolerances of the elderly.

2.2 Core Theories of Western Herbalism: Vitalism and the Adaptogen Hypothesis

The evolution of Western Herbalism is similarly anchored in profound empirical science. Early Western herbal traditions were established upon "Vitalism," which asserts that the human body is not merely a mechanical entity driven solely by physical and chemical laws, but is infused with a vital force or life energy responsible for maintaining homeostasis. When this vital energy becomes obstructed or depleted due to aging, environmental stress, or improper nutrition, disease manifests. The objective of the Western herbalist is not to directly suppress a isolated symptom—as is common with synthetic pharmaceuticals—but to use botanical remedies to eliminate metabolic obstructions, fortify the "vital force," and empower the organism to restore its own internal equilibrium.

With the intervention of modern pharmacology in the mid-20th century, Western Herbalism experienced a major theoretical breakthrough with the formulation of the "Adaptogen" hypothesis. Initially proposed by the Soviet pharmacologist Nikolai Lazarev and later refined by Israel Brekhman, an adaptogen was defined as a natural agent that increases an organism's non-specific resistance to a wide spectrum of physical, chemical, or biological stressors, exerts a normalizing effect on physiology, and causes minimal to no disruption to normal bodily functions. In geriatric care, the adaptogen hypothesis carries extraordinary clinical value. Western Herbalism posits that the aging process is essentially the progressive erosion of the organism's capacity to adapt to environmental and internal stressors. By administering adaptogenic herbs, clinicians can effectively modulate the Hypothalamic-Pituitary-Adrenal (HPA) axis and regulate cortisol secretion, thereby enabling an exhausted geriatric organism to re-establish physiological homeostatic stability.

2.3 The Modern Scientific Convergence Point: The Neuroendocrine-Immune (NEI) Network

When we strip away the traditional nomenclature of Yin-Yang/Five Elements from TCM and the vitalistic language from Western Herbalism, and view them through the prism of contemporary biomedicine, an extraordinary scientific convergence emerges within the Neuroendocrine-Immune (NEI) Network. Contemporary medicine has confirmed that human senescence, along with its attendant chronic pathologies, is microscopically manifested as the progressive desynchronization and breakdown of the NEI network. The attenuation of hypothalamic regulatory controls, the disruption of endocrine hormone secretion rhythms, and the onset of "immunosenescence" operate in a circular, mutually exacerbating pathological loop.

Scientific research demonstrates that classical "Qi-tonifying, Kidney-replenishing, and Fuzheng" herbs in TCM (such as Astragalus membranaceus, Ganoderma lucidum, and Epimedium brevicornu) and the premier "adaptogens and immunomodulators" of Western Herbalism (such as Rhodiola rosea and Withania somnifera / Ashwagandha) share identical molecular targets at the sub-cellular level. These natural botanicals are uniformly rich in bioactive plant polysaccharides, triterpenoid saponins, and total flavonoids. Upon entering the biological system, these micro-components modulate the HPA axis to mitigate neuroendocrine stress. Concurrently, they act on crucial transcription factors (such as inhibiting NF-κB and activating Nrf2) to regulate the transcription and release of systemic cytokines (such as IL-6 and TNF-α), thereby blocking the progression of chronic low-grade inflammation ("inflammaging"). Thus, the Chinese concept of "tonifying vital energy" and the Western paradigm of "stress adaptation" converge seamlessly upon the scientific substrate of the NEI network, providing an immutable pharmacological validation for their integrated application.


III. Clinical Applications and Molecular Mechanisms of Core East-West Herbal Components in Geriatric Healthcare

3.1 The Immune and Endocrine Systems: Countering Fatigue, Immunosenescence, and Metabolic Dysregulation

Geriatric senescence is characterized by immunosenescence, marked by the exhaustion of the naive T-cell pool, diminished macrophage phagocytic capacity, and heightened vulnerability to exogenous pathogens. TCM conceptualizes this state as "deficiency of upright Qi, causing vulnerability to external pathogenic factors." In this domain, Astragalus membranaceus and Panax quinquefolius exhibit superior efficacy in fortifying vital resistance and modulating the endocrine-immune axis.

3.1.1 Recomposition of the Immune Network by Astragalus membranaceus

Long venerated in TCM as the paramount herb for tonifying Qi, Astragalus membranaceus (Huangqi) functions to augment vital energy, consolidate the protective exterior (Weifen), and arrest excessive perspiration. Modern phytochemistry reveals that its primary bio-active constituents are Astragalus Polysaccharides (APS) and Astragaloside IV. In models of immunosenescence, APS specifically activates macrophages and Natural Killer (NK) cells. By upregulating the Toll-like Receptor 4 (TLR4) signaling cascade, APS promotes the transcription and release of Interleukin-2 (IL-2) and Interferon-gamma (IFN-γ), successfully reversing the skewed Th1/Th2 cytokine equilibrium typical of the elderly.
Of milestone significance, Astragaloside IV has been identified as a potent, naturally occurring telomerase activator. Because cellular senescence is inherently coupled with telomere attrition during repeated cell divisions, Astragaloside IV activates the PI3K/Akt signaling pathway to indirectly upregulate the expression of Telomerase Reverse Transcriptase (TERT). This mechanism delays the replicative senescence of Peripheral Blood Mononuclear Cells (PBMCs), effectively fortifying non-specific immunity and cellular endurance at the genomic level.

[Astragaloside IV Molecular Pathway]:

Astragaloside IV ──> Activates PI3K/Akt Pathway ──> Upregulates TERT ──> Delays Replicative Senescence

3.1.2 Adaptogenic Effects and Glycemic Optimization by Panax quinquefolius

Native to North America, Panax quinquefolius (American Ginseng / Xiyangshen) was integrated into high-tier TCM formulations during the Qing Dynasty. Distinct from the warm, thermal property of Asian Ginseng (Panax ginseng), American Ginseng possesses a cooling, moistening profile that tonifies Qi while nourishing Yin and clearing deficiency heat. This makes it uniquely suited for geriatric patients presenting with "Qi and Yin Deficiency accompanied by internal heat."
Contemporary evidence-based medicine classifies Panax quinquefolius as a highly effective adaptogen. Its rich complement of protopanaxadiol saponins (e.g., Ginsenosides Rb1, Rc) principally targets the regulation of the HPA axis. Under chronic, age-related duress, elderly individuals display sustained hypercortisolemia (excess cortisol), which drives bone resorption, sarcopenia, and impaired glucose tolerance. Ginsenosides from American Ginseng bidirectional-regulate adrenocorticotropic hormone (ACTH) secretion, lowering plasma cortisol concentrations and alleviating neuroendocrine stress.
Simultaneously, Ginsenoside Rb1 acts as a potent activator of AMPK (AMP-activated protein kinase). By triggering the AMPK/GLUT4 signaling axis, it accelerates glucose transporter 4 (GLUT4) translocation to the plasma membrane, enhancing glucose uptake in skeletal muscle cells and optimizing insulin sensitivity. This provides profound metabolic support for managing insulin resistance and geriatric type II diabetes.


3.2 Cognitive and Neurological Healthcare: Retarding Cognitive Decay and Neuroprotection

Age-associated memory impairment, cognitive decline, and Alzheimer’s disease (AD) are microscopically driven by the deposition of amyloid-beta (Aβ) plaques, hyperphosphorylated Tau protein tangles, and microglia-mediated neuroinflammation. In countering neurodegeneration, Ganoderma lucidum and Quercetin demonstrate a powerful synergistic bridge between Eastern and Western pharmacological models.

3.2.1 Neuroprotective and Stem Cell Regenerative Properties of Ganoderma lucidum

In the foundational TCM canon Shennog Bencao Jing, Ganoderma lucidum (Lingzhi / Reishi) is categorized as a superior medicine capable of "alleviating chest oppression, tonifying heart Qi, nourishing the center, and augmenting wisdom to prevent forgetfulness." TCM employs its "Heart-nourishing and spirit-tranquilizing" virtues to treat insomnia, amnesia, and cognitive disorientation stemming from Qi and Blood deficiencies.
Modern pharmacology has isolated Ganoderma Triterpenoids and Ganoderma Polysaccharides as its principal drivers. In neurodegenerative disease models, Ganoderma triterpenoids exhibit profound microglial inhibitory activity. They suppress the nuclear translocation of the transcription factor NF-κB, thereby blocking the transcription and release of neurotoxic pro-inflammatory cytokines such as Tumor Necrosis Factor-alpha (TNF-α) and Interleukin-1 beta (IL-1β), halting the cascade of neuroclonal apoptosis.
Furthermore, recent investigations demonstrate that Ganoderma polysaccharides promote the proliferation and differentiation of neural progenitor cells within the dentate gyrus of the hippocampus. By upregulating Brain-Derived Neurotrophic Factor (BDNF) and its cognate receptor TrkB, it enhances synaptic plasticity, providing definitive neuro-structural verification for the traditional claim of "augmenting wisdom and preventing forgetfulness."

[Ganoderma Triterpenoids Anti-Neuroinflammatory Pathway]:

Ganoderma Triterpenoids ──| Blocks NF-κB Nuclear Translocation ──| Inhibits Microglial Activation ──> Reduces Pro-inflammatory Cytokines (TNF-α, IL-1β) ──> Neuroprotection

3.2.2 Senolytic Cleansing and Antioxidant Fortification by Quercetin

Quercetin is a natural polyphenolic flavonoid widely distributed across Western herbal preparations (such as Ginkgo biloba and St. John's Wort) and various botanicals, serving as a cornerstone molecule in modern naturopathic therapies. In geriatric neurology, Quercetin's most vanguard contribution lies in its identification as a premier Senolytic agent.
As the brain ages, astrocytes and neurons enter an irreversible state of cell-cycle arrest, transforming into senescent cells that secrete the "Senescence-Associated Secretory Phenotype (SASP)," which poisons neighboring healthy tissues. Quercetin targets and disrupts the pro-survival anti-apoptotic networks (specifically the BCL-2/BCL-XL pathways) unique to senescent cells, selectively steering these "zombie cells" toward programmed apoptosis and purging the central nervous system of its cryptic inflammatory burden.
Concurrently, Quercetin functions as an exceptional Nrf2 activator. It induces the nuclear translocation of the Nrf2 transcription factor, launching the gene expression of endogenous antioxidant enzymes, including Superoxide Dismutase (SOD), Catalase (CAT), and Glutathione Peroxidase (GSH-Px). This multi-targeted antioxidant defense neutralizes Reactive Oxygen Species (ROS) within cerebral microvessels, preserving blood-brain barrier (BBB) integrity and preventing systemic neurotoxins from infiltrating the central nervous system.


3.3 Cardiovascular and Microcirculatory Preservation: Endothelial Protection and Anti-Atherosclerosis

Vascular endothelial dysfunction and arterial stiffening represent the primary pathological substrates for geriatric hypertension, myocardial infarction, and cerebrovascular accidents. Western natural medicine places immense emphasis on utilizing natural polyphenols to combat vascular oxidative stress and fibrosis, with Grape Seed Extract and Quercetin representing a gold-standard combination.

3.3.1 Collagen Preservation and Nitric Oxide Homeostasis by Grape Seed Extract

The primary active compounds within Grape Seed Extract (GSE) are Oligomeric Proanthocyanidins (OPCs), which represent some of the most potent natural free-radical scavengers known, with antioxidant capacities significantly outstripping Vitamins E and C.
In geriatric cardiovascular pathology, the oxidation of low-density lipoprotein (ox-LDL) constitutes the initiating step in atheromatous plaque formation. The OPCs within GSE bind with high affinity to elastin and collagen fibers within the arterial wall, constructing a molecular shield that prevents enzymatic degradation and free-radical cleavage of the vascular extracellular matrix.
Crucially, GSE activates endothelial Nitric Oxide Synthase (eNOS), stimulating endothelial cells to synthesize and liberate Nitric Oxide (NO). NO serves as the core gaseous signaling molecule responsible for maintaining vascular compliance and vasodilation. As vascular endothelium stiffens with age, baseline NO release drops precipitously. By sustaining NO homeostasis, GSE drives vascular smooth muscle relaxation, reduces peripheral vascular resistance, and serves as a gentle, long-acting regulator of systolic blood pressure in elderly hypertensive cohorts.

[Grape Seed Extract Cardiovascular Pathway]:

OPCs ──> Activates eNOS ──> Promotes Nitric Oxide (NO) Release ──> Relaxes Smooth Muscle ──> Minimizes Peripheral Resistance

3.3.2 Interception of Advanced Glycation End-Products (AGEs) by Flavonoid-Polyphenol Synergism

The arterial walls of geriatric patients undergo severe "glycation degeneration." Over time, elevated circulating reducing sugars react non-enzymatically with vascular collagen, forming irreversible Advanced Glycation End-Products (AGEs). AGEs cross-link structural collagen, causing complete loss of arterial elasticity, and ligate to the Receptor for Advanced Glycation End-products (RAGE) on endothelial surfaces, fueling chronic vasculitis.
Quercetin and Grape Seed Extract deploy a powerful synergistic effect against this axis. Quercetin chelates transition metal ions, interrupting the initial oxidation stages required for early glycation intermediates. Simultaneously, grape seed proanthocyanidins competitively bind to collagen fibers, physically preventing AGEs from binding to and altering the extracellular matrix. Their combined application slows the biological stiffening of both the aorta and peripheral microvasculature.


3.4 Musculoskeletal and Joint Health: Chondroprotection and Bone Turnover Regulation

Degenerative joint disease (osteoarthritis) and osteoporosis are the primary drivers of mobility restriction and declining quality of life in senescent populations. TCM posits that "prolonged physical inactivity weakens the bones, and failure of the Kidney leads to bone decay." In this domain, the macro-regulatory "Kidney-tonifying and bone-strengthening" virtues of traditional herbs complement the precise anti-inflammatory mechanisms of Western plant flavonoids.

3.4.1 Bidirectional Macroscopic Bone Turnover Regulation by Astragalus and Ganoderma

In bone biology, the clinical combination of the Qi-replenishing properties of Astragalus and the Kidney-nourishing attributes of Ganoderma maps precisely to molecular bone turnover pathways. Astragaloside IV upregulates the Wnt/β-catenin signaling pathway, forcing bone marrow mesenchymal stem cells (BMSCs) to differentiate preferentially into osteoblasts, accelerating calcium salt deposition and elevating Bone Mineral Density (BMD).
Concurrently, the polysaccharide fractions of Ganoderma downregulate the expression of Receptor Activator of Nuclear Factor-κB Ligand (RANKL), suppressing the hyperactive bone-resorption profiles of osteoclasts. This dual mechanism of "osteoblast promotion coupled with osteoclast suppression" ensures that these natural components mitigate geriatric osteoporosis with a lower incidence of systemic side effects compared to synthetic estrogen replacements or bisphosphonates.

3.4.2 Targeted Chondroprotective Inhibition of Matrix Metalloproteinases by Quercetin

Within the localized microenvironment of arthritic joints, chondrocytes subjected to mechanical stress and inflammatory cytokines secrete high levels of Matrix Metalloproteinases (MMPs, particularly MMP-13) and A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTSs). These enzymes act as molecular shears, cleaving type II collagen and aggrecan within the articular cartilage, causing cartilage erosion and osteophyte formation.
Quercetin is heavily utilized in Western natural protocols as a premier chondroprotective anti-inflammatory agent. Molecular docking and targeting assays reveal that Quercetin blocks the MAPK/AP-1 signaling cascade, completely arresting the gene transcription of MMP-3 and MMP-13. While protecting articular cartilage from matrix degradation, it concurrently inhibits Cyclooxygenase-2 (COX-2) activity, suppressing the synthesis of Prostaglandin E2 (PGE2). This mechanism mirrors the therapeutic efficacy of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs like Ibuprofen) but avoids inhibiting COX-1, which safeguards the gastric mucosa. Consequently, Quercetin bypasses the severe risks of gastric perforation and gastrointestinal hemorrhage associated with long-term NSAID use in elderly patients.


IV. Contemporary Evidence-Based Methods and Analytical Strides in Herbal Research

4.1 Phytochemical Fingerprinting and Multi-Target Network Pharmacology

With advancements in analytical chemistry, herbal medicine has evolved from an empirical practice into a precise, molecular-driven science. Utilizing High-Performance Liquid Chromatography (HPLC), High-Resolution Mass Spectrometry (HRMS), and Network Pharmacology, researchers can precisely map the complex active chemical finger-prints of natural botanicals. Research into Astragalus, Ganoderma, Panax quinquefolius, Quercetin, and Grape Seed Extract confirms that these agents do not operate via a single, isolated receptor target. Instead, they deploy a "multi-component, multi-target, multi-pathway" network that systematically stabilizes the internal environment of the aging organism. This multi-layered regulatory approach is uniquely suited for managing the interconnected chronic diseases of geriatric patients.

4.2 Randomize Controlled Trials (RCTs) and Large-Cohort Validations

Under the framework of Evidence-Based Medicine (EBM), the clinical efficacy of both Eastern and Western herbs in geriatric care has been extensively validated by Randomize Controlled Trials (RCTs) and Systematic Reviews:

·                                 American Ginseng and Total Saponins: In multiple double-blind RCTs evaluating chronic fatigue and type II diabetes in elderly cohorts, subjects administered standardized extracts (such as a standardized 5% ginsenoside formulation) exhibited significant improvements in Glycated Hemoglobin (HbA1c) levels and fasting insulin sensitivity, combined with excellent clinical safety profiles.

·                                 Grape Seed Proanthocyanidins and Quercetin: Longitudinal cohort studies utilizing high-purity flavonoids and polyphenols demonstrated a significant increase in Flow-Mediated Dilation (FMD) of the brachial artery, accompanied by sustained stabilization of systolic blood pressure. These high-tier evidence-based datasets are dispelling the misconception that herbal medicine lacks objective scientific verification, securing its place within mainstream preventive geriatrics.


V. Clinical Safety, Drug-Herb Interferences, and Risk-Mitigation Frameworks in the Elderly

Because aging is accompanied by a physiological contraction in hepatic volume, a reduction in splanchnic blood flow, and a natural decline in Cytochrome P450 (CYP450) enzyme activity, renal glomerular filtration rates are concurrently depressed. When elderly patients concurrently ingest foundational western pharmaceuticals alongside prolonged, unsupervised, or high-dose herbal and natural extracts, the risk of severe Herb-Drug Interactions (HDIs) escalates exponentially. This represents one of the most critical safety issues in contemporary geriatric medicine.

5.1 Pharmacokinetic Interactions: CYP450 Isoenzyme Competition and Inhibition

Herbal components frequently act as potent inhibitors or inducers of the hepatic CYP450 enzyme system, profoundly altering the circulating serum concentrations of co-administered western medications.

5.1.1 CYP3A4 and CYP2C9 Inhibition by Quercetin and Grape Seed Extract

The polyphenolic and flavonoid structures within Quercetin and Grape Seed Extract (GSE) serve as highly competitive inhibitors of CYP3A4 and CYP2C9 enzymes in both the intestinal mucosa and the liver.

·                                 The Statin Conflict: Widely prescribed geriatric cardiovascular medications (such as Atorvastatin and Simvastatin) depend entirely on the CYP3A4 pathway for metabolic clearance. If an elderly patient takes high-dose Quercetin or Grape Seed Extract capsules alongside their statin prescription for antioxidant purposes, the metabolic clearance of the statin is blocked. This causes a multifold surge in systemic drug concentration, drastically elevating the clinical risks of life-threatening Rhabdomyolysis (skeletal muscle breakdown) and acute hepatotoxicity.

·                                 The Antihypertensive Conflict: Similarly, Calcium Channel Blockers (CCBs like Nifedipine and Amlodipine) are metabolized via this identical enzymatic pathway. Herbal-induced inhibition of their metabolism leads to dangerously high serum concentrations, precipitating sudden orthostatic hypotension, syncope, or reflex tachycardia in fragile elderly individuals.

[CYP3A4 Enzymatic Interception Pathway]:

Quercetin / Grape Seed Extract ──| Potently Inhibits CYP3A4 Enzyme ──| Blocks Statin Clearance ──> Serum Concentration Surges ──> Triggers Rhabdomyolysis

5.1.2 CYP2C9 Induction by Panax quinquefolius and Warfarin Failure

Conversely, long-term administration of Panax quinquefolius (American Ginseng) has been clinically shown to act as a potential inducer of CYP2C9. The narrow therapeutic-index anticoagulant drug, Warfarin, is primarily cleared via CYP2C9. The introduction of American Ginseng accelerates the metabolic clearance of Warfarin, causing a sharp drop in serum drug levels and a dangerous decline in the International Normalized Ratio (INR). Consequently, the anticoagulant therapy intended to prevent ischemic stroke or deep vein thrombosis in patients with atrial fibrillation fails, increasing the risk of thromboembolic events.


5.2 Pharmacodynamic Interactions: Cumulative Bleeding Cascades via Overlapping Antiplatelet Targets

Pharmacodynamic interactions occur when herbs and synthetic drugs exert additive or antagonistic biological effects directly within the physiological system. In geriatric patient populations, the most life-threatening pharmacodynamic conflict occurs within the coagulation cascade.

5.2.1 Combining Blood-Invigorating Herbs, Polyphenols, and Antiplatelet Western Drugs

Large cohorts of elderly patients with cardiovascular diseases require long-term antiplatelet or anticoagulant therapies, such as Aspirin or Clopidogrel.

·                                 Chinese Herb Accumulation: Classical blood-activating and stasis-transforming Chinese herbs (such as Salvia miltiorrhiza / Danshen and Panax notoginseng / Sanqi), containing components like salvianolic acids and notoginsenosides, possess strong intrinsic anti-fibrinogenic and anti-platelet aggregation activities.

·                                 Western Herb Accumulation: Simultaneously, Western natural remedies such as Grape Seed Extract (OPCs), Ginkgo biloba, and high-dose Quercetin have all been shown to inhibit collagen-induced platelet activation.

·                                 Clinical Consequences: When Aspirin is combined with these blood-activating Chinese herbs or Western polyphenolic extracts, their antiplatelet effects undergo a powerful synergistic amplification. This causes a severe depression of the coagulation cascade. Under this unmonitored state, elderly patients are at risk for spontaneous gastrointestinal major hemorrhage, severe epistaxis, or catastrophic, fatal hemorrhagic stroke (intracranial bleeding) from minor trauma or without obvious cause.

[Coagulation Cascade Overlap Pathway]:

Aspirin (Western Drug) + Danshen/Sanqi (Chinese Herb) + Grape Seed Extract (Western Polyphenol) ──> Synergistic Antiplatelet Amplification ──> Coagulation Cascade Failure ──> Catastrophic Intracranial/GI Hemorrhage


5.3 Cross-Cultural Therapeutic Blind Spots and Scientific Countermeasures

5.3.1 The Cross-Cultural Blind Spot: Extract Monotherapy vs. Complex Formulas

Western naturopathic preparations are primarily administered as isolated, "Standardized Extracts" encapsulating a single molecule (e.g., a capsule containing 95% pure Quercetin), making their chemical profiles closely resemble synthetic western pharmaceuticals. In contrast, Traditional Chinese Medicine utilizes multi-ingredient "Decoctions (Formulae)" cooked together, adhering to the intricate structural laws of Jun-Chen-Zuo-Shi (Sovereign, Minister, Assistant, Courier) to balance the formulation. Many elderly individuals lack sufficient clinical pharmacology literacy and frequently ingest high-potency Western herbal extracts simultaneously with complex Chinese decoctions. The high concentrations in Western extracts can disrupt the refined balance of a Chinese formula, triggering drug accumulation, formula neutralization, or unexpected toxicity.

5.3.2 Strategic Scientific Countermeasures

To ensure the elderly can leverage the therapeutic benefits of natural medicine while avoiding safety risks, the following clinical countermeasures must be implemented:

1.                              Enforcement of Integrated Cross-Disciplinary Medication Reviews: Medical systems must establish a mandatory, collaborative review protocol linking traditional practitioners, western clinicians, and clinical pharmacists. Before prescribing synthetic pharmaceuticals or recommending herbal supplements to a geriatric patient, a complete combined medication history must be screened using medical software to identify potential CYP450 conflicts and coagulation risks.

2.                              Strict Implementation of Staggered-Administration Protocols: Clinical guidelines must explicitly instruct elderly patients to maintain a strict 1.5 to 2-hour interval between ingesting natural herbal supplements and foundational western drugs. This temporal separation avoids direct physical or chemical chelation within the gastrointestinal tract (such as herbal polyphenols binding to metallic ions in western pharmaceuticals) and prevents hepatic metabolic enzymes from experiencing acute competitive overload.

3.                              Individualized Therapeutic Drug Monitoring (TDM):For elderly patients on critical narrow therapeutic-index medications such as Warfarin, Statins, or Digoxin, adding any herbal supplement necessitates routine (e.g., bi-weekly) monitoring of INR values, Creatine Kinase (CK) levels, and liver/renal function panels. This allows for dynamic dosage calibrations to ensure clinical safety.


VI. Conclusion and Future Perspectives

6.1 Final Summary

This study systematically examines the clinical utility of Chinese and Western herbal medicines in geriatric care from an intercultural perspective. Through a molecular pharmacological analysis of core botanical components—including Astragalus membranaceus, Ganoderma lucidum, Panax quinquefolius, Quercetin, and Grape Seed Extract—this paper confirms the unique benefits of natural therapies in combating immunosenescence, delaying cognitive decline, preserving cardiovascular health, and protecting the musculoskeletal framework via multi-targeted networks. The holistic "Zheng-strengthening" philosophy of Chinese medicine and the micro-level "adaptogenic and antioxidant" mechanisms of Western Herbalism achieve deep scientific alignment within the modern neuroendocrine-immune (NEI) network and cellular senescence signaling pathways. However, due to age-related declines in metabolic efficiency, competitive interactions at hepatic Cytochrome P450 enzyme sites and overlapping anticoagulation pathways represent significant safety risks. This underscores the imperative that natural herbal integration must be guided by rigorous evidence-based clinical protocols and robust safety frameworks.

6.2 Future Outlook and Longevity Industry Integration

Looking forward, the strategic convergence of Chinese and Western natural herbs within geriatric medicine will serve as a vital driver for achieving "Healthy Ageing":

1.                              Precision Intercultural Product R&D: The global longevity industry must transcend traditional cultural boundaries by synthesizing the holistic, macro-synergistic thinking of Chinese formula design with modern Western high-purity extraction technologies (such as standardized flavonoids and polyphenols). Leveraging network pharmacology and genomic screening will enable the development of an advanced generation of "East-West fusion" natural longevity formulations that simultaneously balance systemic homeostasis with precise molecular targeting.

2.                              Intelligentized Clinical Safety Infrastructure: To address the critical issue of polypharmacy in the elderly, the medical community must prioritize building a standardized, international "Herb-Drug Interaction (HDI)" database. Integrating these datasets into AI-driven medical prescription systems will enable real-time risk interception and provide automated, personalized staggered-administration protocols, eliminating cross-disciplinary blind spots.

3.                              Constructing a Comprehensive Macro-Geriatric Healthcare Paradigm: This study calls for a structural evolution in global healthcare models toward a balanced system where natural therapies and modern synthetic medicine complement one another. Positioning safe, evidence-based natural herbs at the forefront of preventative medicine and early-stage senescence management can reduce over-reliance on synthetic pharmaceuticals, lowering systemic side effects and significantly improving the functional healthspan and quality of life for the aging population.

 

References

1.                              Brekhman, I. I., & Dardymov, I. V. (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology, 9(1), 419-430.

2.                              Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology: Series A, 69(Suppl_1), S4–S9.

3.                              Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012). An overview of the evidence and mechanisms of herb–drug interactions. Frontiers in Pharmacology, 3, 69.

4.                              Kirkland, J. L., & Tchkonia, T. (2020). Senolytic drugs: From discovery to translation. Journal of Internal Medicine, 288(5), 518-536.

5.                              Auyeung, K. K., Han, Q. B., & Ko, J. K. (2016). Astragalus membranaceus: A review of its protection against inflammation and gastrointestinal cancers. The American Journal of Chinese Medicine, 44(01), 1-22.

6.                              Szewczyk, K., & Miazga-Karska, M. (2021). Panax quinquefolius L. (American Ginseng) as an adaptogen: A review of its chemistry and pharmacology. Nutrients, 13(11), 4056.

7.                              Zhang, Y., & Wang, D. (2018). Ganoderma lucidum (Reishi mushroom) triterpenoids and polysaccharides: Inhibiting neuroinflammation in Alzheimer’s disease models. International Journal of Molecular Sciences, 19(11), 3542.

8.                              Sano, T., & Williamson, E. M. (2019). Cardiovascular benefits of grape seed proanthocyanidins: Mechanisms of endothelial nitric oxide synthase (eNOS) activation. Phytomedicine, 56, 122-130.

9.                              Tarirai, C., & Viljoen, A. M. (2010). Herb-drug interactions: The impact of flavonoids and polyphenols on CYP3A4 and P-glycoprotein. Journal of Ethnopharmacology, 128(2), 263-281.

10.                         Yuan, C. S., & Wang, C. Z. (2004). Brief communication: American ginseng reduces the anticoagulant effect of warfarin in a randomized trial. Annals of Internal Medicine, 141(1), 23-27.

11.                         Zhang, T. J., & Liu, C. X. (2016). Study on quality marker (Q-Marker) of Chinese materia medica: A modern phytochemical approach to enhance efficacy and safety. Chinese Traditional and Herbal Drugs, 47(1), 1-9.

12.                         Wang, Y. Y., & Lu, Z. L. (2008). Geriatric medical thoughts in Huangdi Neijing and the value of preventive treatment of disease in modern chronic disease management. Journal of Traditional Chinese Medicine, 49(3), 197-200.

13.                         Li, X. D., & Chen, K. J. (2019). Bleeding risk and clinical risk control strategies of combined application of blood-activating stasis-resolving Chinese medicine and antiplatelet Western medicine. Chinese Journal of Integrated Traditional and Western Medicine, 39(8), 912-915.

14.                         National Pharmacopoeia Committee. (2025). Pharmacopoeia of the People's Republic of China (2025 Edition). Beijing: China Medical Science and Technology Press.

15.                         Liu, J. P. (2015). Methodological discussion on evidence-based clinical research of traditional herbal medicine in modern geriatrics. Chinese Journal of Evidence-Based Medicine, 15(4), 481-486.

  

跨文化视角下中西方草药在老年保健中的互补应用与循证医学研究

Charles Cheng Xia

摘要

摘要:全球人口老龄化加剧了多病共存与衰老相关慢性低度炎症(Inflammaging)的临床挑战。现代西医多药联合用药(Polypharmacy)易导致老年人肝肾毒性及药物蓄积。本研究立足于跨文化视角,系统探讨了东方传统中医学(TCM)与西方自然疗法草药学(WesternHerbalism)在老年保健中的互补应用。通过对黄芪、灵芝、西洋参、槲皮素和葡萄籽提取物等核心成分的分子药理学剖析,揭示了中药“扶正固本”与西方“适应原、多酚抗氧化”理论在现代神经内分泌免疫(NEI)调控网络、端粒酶激活、Senolytic(衰老细胞裂解)及Nrf2、NF-κB等信号通路上的科学交汇。同时,本研究深入评估了草药与西药在肝脏细胞色素P450(CYP450)酶系竞争(如CYP3A4抑制)及抗凝血靶点叠加(如阿司匹林与活血化瘀药合用引发的出血风险)等药代与药效动力学层面的临床冲突。最后,提出了构建中西医融合的大健康老龄化保健模式、建立智能化草-西药相互作用(HDI)数据库以及实施个性化时差用药的科学风控对策,为未来国际大健康产业中天然草本产品的融合研发提供了循证医学支撑。

关键词:老龄化;中草药;西方自然疗法;神经内分泌免疫网络(NEI);草药-西药相互作用(HDI);循证医学

一、 引言(Introduction)

1.1 研究背景:全球老龄化与慢性病管理的严峻挑战

21世纪以来,全球人口结构正经历着前所未有的深刻变迁,人口老龄化已成为世界各国面临的共同挑战。随着人类平均寿命的延长,老年群体的健康管理重心已从传统的传染性疾病预防,转向了复杂的慢性病与退行性疾病的长期管理。老年人的生理特质具有极高的特殊性与复杂性,其中最核心的特征便是“多病共存”(Multimorbidity)与“衰老相关的慢性低度炎症”(Inflammaging)。随着年龄增长,机体免疫系统逐渐失调,长期处于一种系统性的、非特异性的微炎症状态,这种状态是阿尔茨海默症、心脑血管疾病、II型糖尿病及骨质疏松症等多种老年疾病的共同病理基础。

然而,现代生物医学(西医)在应对老年多系统慢性病时,往往采取“一病一药”的对抗疗法。这直接导致了老年群体中极其普遍的“多药联合用药”(Polypharmacy)现象。多项临床调研显示,罹患多种慢性病的老年人平均每日需服用5至10种不同的化学药物。由于老年人肝脏细胞色素P450酶系活性降低,肾小球滤过率显著下降,药物在体内的代谢与排泄速度大幅减缓。多药并用不仅极易引发严重的药物蓄积中毒,还会因药物间复杂的化学相互作用,导致肝肾功能损伤、胃肠道黏膜屏障破坏等不良反应。因此,探索一种更为温和、安全且具备多靶点调节特性的整体主义保健与治疗模式,已成为国际老年医学界亟待解决的重大课题。

1.2 跨文化草药学的研究价值

在此背景下,草药(HerbalMedicine)作为人类医学文明的共同财富,其独特的保健与治疗价值重新获得了国际学术界的广泛关注。东方传统中医学(Traditional Chinese Medicine, TCM)与西方自然疗法草药学(Western Herbalism)虽然诞生于不同的地理环境与文化土壤,但在面对人类衰老与健康维护这一命题时,却有着共通的哲学智慧。中医学核心的“扶正固本”与“整体观”,强调通过调节人体的气血阴阳平衡来提高机体的抗病能力,其核心理念在于“治未病”,即在疾病显现或恶化前进行系统性调理。与之呼应,西方自然疗法草药学则长期秉持“生命力理论”(Vitalism),主张利用天然植物的药性来激发、支持并顺应人体自身的自愈潜能(Vis Medicatrix Naturae)。

将中草药与西方草药置于同一学术框架下进行跨文化研究,绝非简单的药材堆砌,而是两种天然医学智慧的深度互补。中草药长于复杂的系统辨证与复方配伍,能够针对个体的动态变化进行精准调理;西方草药则在单一植物提取物的标准化(Standardization)、定向靶点作用以及特定生理功能的快速缓解上积累了丰富的现代循证医学数据。这种跨文化的融合研究,能够突破单一传统医学的局限,为现代“健康老龄化”(HealthyAgeing)提供一种既兼顾宏观机能调控,又具备微观科学验证的多元化干预手段。

1.3 本文研究目的与主要内容

本研究旨在系统性地梳理中草药与西方自然疗法草药在老年保健领域的理论交汇点,深入探讨它们在神经系统、免疫内分泌系统、心脑血管系统及运动骨关节系统这四大核心老年保健领域的临床应用与分子药理机制。同时,本文将引入循证医学的最新研究成果,客观分析中西方草药在老年群体实际应用中所面临的临床安全问题、草-西药相互作用(Herb-Drug Interactions)以及跨文化配伍盲区。最终,本文试图为未来国际大健康产业中天然草本产品的融合研发,以及中西草药合并使用的临床安全指南提供切实可行的理论依据。

二、 中西方草药的老年保健理论根基与交汇点(Theoretical Framework)

2.1 中医老龄保健的核心理论:肾精亏虚与治未病

中医学对人类衰老机制的认识历史悠久。《黄帝内经》中关于女子“七七”、男子“八八”机能渐衰的论述,深刻揭示了衰老的必然规律。中医学认为,老年衰老与慢病多发的根本病理机制在于“肾精亏虚、气血失调”。中医视“肾”为先天之本,主骨生髓,藏精并主生长发育与衰老。人至老年,肾气渐衰,肾精亏耗,进而导致髓海不足、骨枯肉萎。由于先天之精的化生不足,后天之气血亦随之衰少,气虚则无力推动血液运行,导致“气滞血瘀”;血虚则无以濡养脏腑,致使五脏六腑功能全面衰退。因此,中医在老年保健上,核心法则在于“扶正固本、调理气血”,即通过补益真阴元气、活血化瘀,来延缓器官的退行性病变。

此外,中医“治未病”思想在老年保健中具有决定性意义。老年人的健康状态往往处于一种高风险的“未病”或“欲病”状态,即虽然现代医学理化指标可能尚在正常临界值内,但机体平衡已严重倾斜。中医学通过辨证施治,不纠结于单一物理指标的消除,而是通过调理阴阳平衡,在疾病尚未对脏腑造成器质性实质损害之前进行截断与扭转,这极大地契合了老年人脆弱的生理耐受力。

2.2 西方自然疗法草药的核心理论:生命力与适应原假说

西方自然疗法草药学的发展同样根植于深刻的经验科学。早期的西方草药学建立在“生命力理论”(Vitalism)之上,认为人体并非单纯由物理和化学规律驱动的机械体,而是充满了一种维持生命平衡的“生命能量”。当这种能量因衰老、环境压力或不当饮食而受阻或减弱时,疾病便会发生。西方草药师的任务并非像现代合成西药那样去直接压制某种症状,而是使用植物药来移除体内的毒素阻碍,增强“生命力”,让身体恢复自我调节。

随着现代药理学的介入,西方草药学在20世纪中叶迎来了理论的重大突破——“适应原”(Adaptogens)假说的提出。这一理论由前苏联科学家Lazarev提出,并由Brekhman等人深化。适应原被定义为一类能够提升机体对物理、化学及生物学等各种非特异性压力源的抵抗力,且对机体正常生理功能无干扰、具有双向调节和正常化作用(NormalizingEffect)的天然物质。在老年保健中,适应原假说具有极高的应用价值。西方草药学认为,老年人的衰老过程本质上是机体对环境和内部压力适应能力的逐渐丧失。通过服用适应原草药,能够有效调节下丘脑-垂体-肾上腺轴(HPA轴),控制皮质醇的过度分泌,从而使处于耗损状态的老年机体重新获得内环境的稳态。

2.3 中西理论的现代科学交汇点:神经内分泌免疫调节网络(NEI)

当我们剥离中医学的阴阳五行话语体系与西方自然疗法的生命力语言,用现代现代生物医学的视角审视时,会发现两者在神经内分泌免疫调节网络(Neuroendocrine-Immune Network, NEI网络 )上实现了高度的科学交汇。现代医学证实,人类的衰老以及由此产生的各种慢性病,其微观表现正是NEI网络的失衡与紊乱。下丘脑的调控功能减退、内分泌激素分泌节律紊乱以及免疫系统的“免疫衰老”(Immunosenescence),三者互为因果,恶性循环。

科学研究表明,中医学中所指的“补气、补肾、扶正”的经典中药(如人参、黄芪、淫羊藿),与西方草药学中所定义的“适应原”和“免疫调节剂”(如红景天、南非醉茄),在现代分子生物学层面上有着惊人的共性靶点。它们均富含植物多糖、三萜皂苷及总黄酮等活性成分。这些微观成分进入人体后,一方面通过调节HPA轴改善神经内分泌应激;另一方面,通过激活或抑制转录因子(如NF-κB、Nrf2),调节细胞因子(如IL-6、TNF-α)的释放,从而阻断“慢性低度炎症(Inflammaging)”的进展。中医的“扶正固本”与西医的“压力适应”,在NEI网络这一现代科学的基石上,完成了完美的理论交融,为两者的互补应用提供了坚实的药理学依据。

三、 中西草药在老年核心保健领域的临床应用与机制(Clinical Applications & Mechanisms)

3.1 免疫与内分泌系统:抗疲劳、抗免疫衰老与代谢调节

老年期最显著的病理改变之一是“免疫衰老”(Immunosenescence),表现为T细胞库的耗竭、巨噬细胞吞噬能力下降,以及机体对外界病原体易感性的增加。中医学将此归结为“正气亏虚,卫外不固”。在这一领域,黄芪与西洋参展现出了极其优异的扶正固本与调节内分泌网络的作用。

3.1.1 黄芪(Astragalus membranaceus)的免疫网络重塑

黄芪作为中医“补气诸药之长”,具有益气固表、敛汗固脱之功效。现代植物化学与分子药理学研究表明,黄芪的核心活性成分为黄芪多糖(Astragalus Polysaccharides, APS)与黄芪甲苷(Astragaloside IV)。在抗免疫衰老方面,黄芪多糖(APS)能特异性地激活巨噬细胞与自然杀伤细胞(NK细胞),通过上调Toll样受体4(TLR4)信号通路,促进白介素-2(IL-2)及干扰素-γ(IFN-γ)的释放,扭转老年人体内Th1/Th2细胞因子的失衡状态。
更具里程碑意义的是,黄芪甲苷被证实是天然的端粒酶激活剂(Telomerase Activator)。衰老本质上伴随着细胞分裂和端粒缩短,黄芪甲苷通过激活PI3K/Akt信号通路,间接上调端粒酶反转录酶(TERT)的表达,延缓外周血单核细胞(PBMC)的复制性衰老,从而从基因和细胞层面增强老年机体的非特异性免疫力与抗疲劳能力。

【黄芪甲苷分子通路】:

黄芪甲苷 ──> 激活 PI3K/Akt 通路 ──> 上调 TERT (端粒酶反转录酶) ──> 延缓细胞复制性衰老

3.1.2 西洋参(Panax quinquefolius)的适应原效应与糖代谢优化

源自北美的西洋参(花旗参)在清代传入中国后,被中医纳入高阶补益药体系。与红参(Panax ginseng)的温热药性不同,西洋参性凉、味甘微苦,具有补气养阴、清热生津的独特功效,极度适合“气阴两虚、虚热内生”的老年群体。
现代循证医学将其归类为高药效的“适应原”(Adaptogen)。西洋参富含的二醇组人参皂苷(如Ginsenoside Rb1、Rc),核心靶点在于调节下丘脑-垂体-肾上腺轴(HPA轴)。老年人在长期慢性应激下,皮质醇(Cortisol)往往分泌过剩,导致骨质疏松、肌肉萎缩及糖耐量异常。西洋参皂苷能双向调节肾上腺皮质激素的分泌,降低血浆皮质醇浓度,缓解机体的神经内分泌压力。
同时,Rb1 皂苷是一种强效的 AMPK(腺苷酸活化蛋白激酶)激活剂。它通过激活 AMPK/GLUT4 信号通路,促进骨骼肌细胞对葡萄糖的摄取,增强胰岛素敏感性,这为老年糖尿病患者或胰岛素抵抗群体的血糖稳态调节提供了强力的分子代谢支持。


3.2 神经系统保健:延缓认知衰老与保护神经元

老龄化伴随的记忆力减退、认知功能障碍乃至阿尔茨海默症(AD),其微观核心病理在于脑内β-淀粉样蛋白(Aβ)沉积、过度磷酸化的Tau蛋白聚集,以及小胶质细胞介导的“神经炎症”。在对抗神经退行性变方面,灵芝与槲皮素展现出了中西药理的联合保护优势。

3.2.1 灵芝(Ganoderma lucidum)的宁心安神与神经干细胞保护

灵芝在中医经典《神农本草经》中被列为上药,主治“胸中结,益心气,补中,增智慧,不忘”。中医利用其“宁心安神、益气补血”来调理老年人因气血不足导致的失眠、健忘和神志恍惚。
现代药理学发现,灵芝的活性成分主要为灵芝总三萜(Ganoderma Triterpenoids)与灵芝多糖。在神经退行性疾病模型中,灵芝三萜显示出极强的小胶质细胞抑制活性。它能够阻断NF-κB信号通路向细胞核内转位,从而抑制肿瘤坏死因子-α(TNF-α)和白介素-1β(IL-1β)等促炎因子的释放,阻断由神经炎症引发的神经元级联凋亡。
此外,最新研究表明,灵芝多糖能促进海马体神经前体细胞的增殖与分化,通过激活脑源性神经营养因子(BDNF)及其受体 TrkB 的表达,提升突触可塑性(Synaptic Plasticity),这为中医“增智慧、不忘”提供了明确的脑神经修复学证据。

【灵芝三萜抗神经炎症通路】:

灵芝三萜 ──| 阻断 NF-κB 核转位 ──| 抑制小胶质细胞活化 ──> 减少促炎因子 (TNF-α, IL-1β) ──> 保护神经元

3.2.2 槲皮素(Quercetin)的 Senolytic 衰老细胞清除与抗氧化屏障

槲皮素是一种广泛存在于西方草药(如银杏叶、圣约翰草)以及日常蔬果中的天然黄酮类化合物,也是现代自然疗法中的明星成分。在老年神经学领域,槲皮素最前沿的贡献在于其作为 Senolytic(衰老细胞裂解剂) 的发现。
随着大脑衰老,星形胶质细胞和神经元进入不可逆的细胞周期停滞状态,并分泌“衰老相关分泌表型(SASP)”,破坏周围健康细胞。槲皮素能够靶向阻断衰老细胞的抗凋亡通路(BCL-2/BCL-XL),特异性地引导这些“僵尸细胞”走向程序性死亡,清除大脑的隐性毒性。
同时,槲皮素是一类高效的 Nrf2 激活剂。它通过诱导 Nrf2 转录因子进入细胞核,启动下游超氧化物歧化酶(SOD)、过氧化氢酶(CAT)及谷胱甘肽过氧化物酶(GSH-Px)等内源性抗氧化酶的基因表达。这种多靶点的抗氧化防御,能够强力清除脑部微血管中的活性氧自由基(ROS),保护血脑屏障(BBB)的完整性,防止毒性物质渗入大脑中枢。

3.3 心脑血管与微循环养护:保护内皮细胞与抑制血管硬化

血管内皮功能障碍和动脉粥样硬化是老年人高血压、心肌梗死及脑卒中多发的主要基础。西方自然疗法极其重视通过天然多酚类物质来对抗血管的氧化应激和纤维化,其中葡萄籽提取物与槲皮素的联用是心血管养护的典型代表。

3.3.1 葡萄籽提取物(Grape Seed Extract)的胶原保护与一氧化氮稳态

葡萄籽提取物(GSE)的核心活性物质为原花青素低聚物(Oligomeric Proanthocyanidins, OPCs),是目前已知最强的天然自由基清除剂之一,其抗氧化能力显著超越维生素E和维生素C。
在老年心血管病理中,低密度脂蛋白(LDL)的氧化(ox-LDL)是形成动脉粥样硬化斑块的起始步骤。GSE中的OPCs能高效结合在血管壁弹性蛋白和胶原蛋白上,形成一层分子保护屏障,防止酶解和自由基对血管结构的破坏。
更为关键的是,葡萄籽提取物能够激活内皮型一氧化氮合酶(eNOS),促进内皮细胞释放一氧化氮(NO)。NO是维持血管张力和顺应性的核心气体信号分子。随着年龄增长,血管内皮硬化,NO释放量骤减。GSE通过维持NO的稳态,促使血管平滑肌舒张,从而有效降低外周血管阻力,实现温和、长效调节老年人收缩压(高血压)的临床效果。

【葡萄籽提取物心血管保护通路】:

原花青素(OPCs) ──> 激活 eNOS ──> 促进一氧化氮(NO)释放 ──> 舒张平滑肌 ──> 降低外周血管阻力

3.3.2 槲皮素与葡萄籽多酚对 AGEs 晚期糖基化终产物的联合截断

老年人的血管壁往往伴随着严重的“糖基化变性”。机体长期代谢产生的游离糖会与血管壁胶原蛋白发生非酶促糖化反应,形成不可逆的晚期糖基化终产物(AGEs)。AGEs会导致血管壁交叉联结、弹性彻底丧失,并与内皮细胞表面的受体(RAGE)结合,诱发慢性血管炎。
槲皮素与葡萄籽提取物在此处展现出强大的协同效应。槲皮素能通过螯合过渡金属离子,从源头上阻断糖化反应的中间体形成;而葡萄籽原花青素则能竞争性地结合胶原纤维,阻止 AGEs 对血管外基质的修饰。两者的联合应用,从微观层面极大地延缓了老年人主动脉及外周微血管的“生理性硬化”进程。

3.4 运动与骨关节系统:抑制软骨降解与缓解骨质疏松

关节退行性变(骨关节炎)和骨质疏松是导致老年人行动受限、生活质量滑坡的主因。中医认为“动摇则骨痿,肾败则骨枯”。在这个版块中,黄芪、灵芝等传统中药的“补肾壮骨”功效,能够与槲皮素等植物黄酮的抗炎止痛机制形成完美的临床互补。

3.4.1 黄芪与灵芝对骨代谢(成骨/破骨细胞)的双向宏观调控

中医学中,黄芪的大补气血与灵芝的滋补肝肾,在现代骨生物学中找到了精确的分子对应。黄芪甲苷被证实能够通过上调 Wnt/β-catenin 信号通路,促进骨髓间充质干细胞(BMSCs)向成骨细胞(Osteoblasts)分化,增强钙盐沉积,提高骨密度。
与此同时,灵芝中的多糖成分能有效下调破骨细胞分化因子(RANKL)的表达,从而抑制破骨细胞(Osteoclasts)
的过度骨吸收活性。这种“促进成骨、抑制破骨”的双向调控机制,使中草药在长线防治老年骨质疏松症中,具有比单一雌激素或双膦酸盐类西药更低的全身不良反应。

3.4.2 槲皮素对软骨基质降解酶的精准靶向抑制

在关节炎的局部微环境中,软骨细胞受到机械应力和炎症刺激,会大量分泌基质金属蛋白酶(MMPs,尤其是MMP-13)以及基质降解酶(ADAMTSs),它们如同剪刀一样剪断关节软骨中的型胶原蛋白和蛋白聚糖,导致软骨磨损和骨刺形成。
槲皮素在西方自然疗法中常被用作天然的关节抗炎剂。分子靶向研究证实,槲皮素通过强效抑制 MAPK/AP-1 信号通路,能够精准阻断 MMP-3 和 MMP-13 的基因转录。在保护关节软骨不被降解的同时,它还能抑制环氧合酶-2(COX-2)的活性,减少前列腺素E2(PGE2)的生成。这一机制与非甾体抗炎药(NSAIDs,如布洛芬)高度相似,但槲皮素不抑制具有胃黏膜保护作用的 COX-1 酶,因此避免了老年人长期服用西药止痛药带来的胃穿孔与消化道出血风险。

四、 现代循证医学对中西草药的研究方法与成果(Evidence-Based Research)

4.1 植物化学与多靶点药理学分析

随着现代分析化学的发展,中西草药的研究已从单纯的经验医学过渡到精准的分子功能科学。利用高效液相色谱法(HPLC)、高分辨率质谱(HRMS)以及网络药理学(Network Pharmacology),科研人员能够精确鉴定出天然植物中复杂的活性成分指纹图谱。以黄芪、灵芝、西洋参等中药以及槲皮素、葡萄籽提取物等西方天然成分为例,现代药理学证实它们并非通过“单一靶点”发挥作用,而是通过“多成分、多靶点、多通路”的协同网络来调理老年机体的内环境稳态。这种整体网络调节方式,恰恰契合了老年人多系统功能衰退、慢病错综复杂的病理生理特性。

4.2 现代临床试验与大型队列研究

在循证医学(Evidence-Based Medicine, EBM)的框架下,中西草药在老年医学中的疗效得到了大量随机对照试验(RCT)及系统评价(Systematic Reviews)的证实。

·                                 西洋参及人参皂苷:在多项针对老年慢性疲劳与2型糖尿病的临床双盲试验中,受试者在服用标准提取物(如标准化5%人参皂苷)后,其糖化血红蛋白(HbA1c)水平及空腹胰岛素敏感性均得到显著改善,且具有极高的耐受性。

·                                 葡萄籽原花青素与槲皮素:血管内皮功能的临床队列研究表明,长期补充这类高纯度黄酮和多酚成分的老年人群,其血流介导的血管舒张功能(FMD)显著增强,收缩压呈现稳定性下降。这些高阶的循证医学数据,逐步打破了传统草药“缺乏科学依据”的刻板印象,为其进入主流老年保健医学奠定了基石。

·                                  

五、 老年人应用中西草药的临床安全、药物相互作用与对策(Safety & Challenges)

老年人由于肝脏体积缩小、血流量减少,导致细胞色素P450(CYP450)酶系活性生理性下降;同时,肾小球滤过率的降低使得药物排泄延迟。当老年患者在服用基础西药的同时,大量、长期或不规范地重叠使用中草药与西方天然保健品时,极易诱发严重的草药-西药相互作用(Herb-Drug Interactions, HDI)。这是目前老年大健康领域最严峻的临床隐患。

5.1 药代动力学冲突:CYP450 酶系的竞争与抑制

药物在体内的代谢主要依赖于肝脏的CYP450酶系统。许多中西草药的核心成分是该酶系的强效诱导剂或抑制剂,从而会剧烈改变合用西药的血药浓度。

5.1.1 槲皮素与葡萄籽提取物对 CYP3A4 和 CYP2C9 的抑制风险

槲皮素(Quercetin)葡萄籽提取物(GSE)富含的多酚黄酮类化合物,在肠道和肝脏中是 CYP3A4  CYP2C9 酶的强效竞争性抑制剂。

·                                 他汀类降脂药冲突:老年人极其常用的心血管西药(如阿托伐他汀、辛伐他汀)完全依赖 CYP3A4 酶进行代谢清除。如果老年患者在服用他汀类药物的同时,为了抗氧化而大剂量补充槲皮素或葡萄籽提取物,会导致他汀类药物在血液中的浓度数倍升高,极大地增加了横纹肌溶解症(Rhabdomyolysis)和急性肝损伤的致死性风险。

·                                 降压药冲突:同理,钙通道阻滞剂(如硝苯地平、氨氯地平)亦通过该通路代谢。草药对其抑制会导致血药浓度过高,引发老年人突发性体位性低血压或反射性心动过速。

CYP3A4 酶系竞争冲突】:

槲皮素 / 葡萄籽提取物 ──| 强效抑制 CYP3A4  ──| 阻断他汀类西药代谢 ──> 血药浓度异常暴增 ──> 诱发横纹肌溶解

5.1.2 西洋参对 CYP2C9 的诱导与华法林失效

与上述抑制作用相反,长期、常规剂量服用西洋参(Panax quinquefolius)被临床证实对 CYP2C9 酶具有潜在的诱导激活作用。西药中窄治疗窗的抗凝血黄金药物——华法林(Warfarin)主要依赖 CYP2C9 代谢。西洋参的引入会加快华法林的清除速度,导致血液中华法林浓度骤降,国际标准化比值(INR)超标下跌,使得原本用于预防脑卒中或房颤栓塞的抗凝治疗彻底失效,显著拔高了老年人脑梗死和深静脉血栓的发生率。

5.2 药效动力学冲突:抗凝、抗血小板靶点的重叠叠加

药效动力学冲突是指草药与西药在生物体内的“生理效应”上产生了相加或拮抗。在老年群体中,最致命的药效动力学冲突集中在凝血系统

5.2.1 活血化瘀中药、西方多酚与抗血小板西药的出血风暴

大多数老年心脑血管患者需要长期服用阿司匹林(Aspirin)氯吡格雷(Clopidogrel)来进行二级预防。

·                                 中药叠加:中医经典的活血化瘀药(如丹参、三七、红花),其核心成分(如丹参素、三七总皂苷)具有强效的抗纤维蛋白形成和抑制血小板聚集作用。

·                                 西方草药多酚叠加:同时,第三章提到的葡萄籽提取物(OPCs)、银杏叶提取物以及高剂量槲皮素,均被证实能抑制胶原蛋白诱导的血小板活化。

·                                 临床后果:当阿司匹林与这些“活血”中草药或西方抗氧化多酚无节制地合用时,抗血小板效应发生几何级数的相加叠加(Synergistic effect)。这会导致老年人凝血功能严重匮乏,在受到微小磕碰或无明显诱因下,极易爆发自发性胃肠道大出血、牙龈严重渗血乃至致命性的脑出血

【凝血靶点叠加冲突】:

阿司匹林(西药) + 丹参/三七(中药) + 葡萄籽提取物(西多酚) ──> 抗血小板效应多重叠加 ──> 凝血级联崩溃 ──> 诱发脑出血/胃出血

5.3 跨文化用药盲区与科学对策

5.3.1 跨文化用药盲区:提取物与复方配伍的混乱

西方自然疗法草药多以“单一标准化提取物(Standardized Extract)”的形式胶囊化服用(如纯度95%的槲皮素),其理化性质更接近化学西药;而传统中草药多以“复方汤剂(Formula)”多味药材共煎服,讲究君臣佐使的相互调和。许多老年人缺乏医学常识,常将西式高纯度草药胶囊与中药大复方汤剂同时吞服。西方提取物的高浓度极易打破中药复方的原定配伍平衡,导致药性冲突、药物蓄积或毒性放大。

5.3.2 科学风控对策

为了确保老年群体享受草药保健红利的同时规避安全红线,临床必须践行以下科学对策:

1.                              实行“医-药”联合监管与用药审查:建立中医师、西医师与临床药师联合会诊机制。在为老年人开具西药处方或建议服用草药前,必须强制调阅患者的完整中西用药清单,利用大数据软件筛查 CYP450 酶系及凝血靶点的潜在冲突。

2.                              严格执行“时差用药原则”:临床指南应明确指导老年患者,中西草药与基础西药的服用时间必须严格错开1.5至2小时以上。这能有效避免不同成分在胃肠道内的直接理化螯合(如某些草药多酚会螯合西药中的金属离子),并减轻肝脏代谢酶在同一时间段内的竞争性超载负荷。

3.                              个性化剂量监测(TDM):对于服用华法林、他汀类、地高辛等窄治疗窗西药的老年人,在加用任何草药保健品期间,必须定期(如每两周)监测凝血INR值、肌酸激酶(CK)及肝肾功能指标,实施动态剂量调整,以确保用药安全。

 

 

六、 结论与未来展望(Conclusion and Future Perspectives)

6.1 全文总结

本研究系统探讨了跨文化视角下中西方草药在老年保健中的应用价值。通过对黄芪、灵芝、西洋参、槲皮素及葡萄籽提取物等核心成分的分子药理学剖析,证实了传统天然药物在抗免疫衰老、延缓认知退化、保护心血管及维护骨关节健康等方面具有多成分、多靶点、多通路的独特优势。中医学宏观的“扶正固本”智慧与西方草药学微观的“适应原”和“植物多酚抗氧化”机制,在现代神经内分泌免疫(NEI)调控网络及细胞衰老信号链上实现了深刻的科学交汇。然而,由于老年人生理代谢机能的减退,草药与传统西药在肝脏细胞色素P450(CYP450)酶系及凝血靶点上的激烈冲突,也构成了不容忽视的临床安全红线。这表明,天然草药的应用必须建立在严谨的循证医学与安全风控体系之上。

6.2 未来展望与大健康产业融合

展望未来,中西方草药在老年医学领域的深度融合将成为实现“健康老龄化”的重要驱动力:

1.                              跨文化精准配伍研发:未来的大健康产业应打破文化壁垒,将东方的辨证复方整体思维与西方现代高纯度植物提取工艺(如标准化黄酮、多酚)深度结合。通过网络药理学与基因组学技术,开发出既具备中医“调和阴阳”宏观协同效应,又符合国际微观定量、靶向精准标准的“中西融合型”新一代老年天然保健品。

2.                              智能化临床安全指南:针对多药联合用药(Polypharmacy)这一核心痛点,亟需建立国际通用的“草药-西药相互作用(HDI)”权威数据库。利用医疗大数据与AI审方系统,为临床医生与患者提供智能化、个性化的用药风险拦截与时差用药规范,彻底消除跨文化用药的盲区。

3.                              大健康老龄化保健模式的构建:呼吁医学界建立一种中西医并重、天然疗法与现代医学互补的综合性慢病管理模式。将天然草药的安全干预前置于“治未病”与早期衰老调理阶段,从而减少老年人对化学合成西药的过度依赖,显著提升老年群体的生命质量与健康预期寿命。

参考文献列表(References)

英文文献(International Peer-Reviewed Journals)

1.                              Brekhman, I. I., & Dardymov, I. V. (1969). New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology, 9(1), 419-430. (适应原假说的经典奠基文献) [1]

2.                              Franceschi, C., & Campisi, J. (2014). Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. The Journals of Gerontology: Series A, 69(Suppl_1), S4–S9. (老年慢性低度炎症核心理论) [2]

3.                              Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012). An overview of the evidence and mechanisms of herb–drug interactions. Frontiers in Pharmacology, 3, 69. (草药-西药相互作用HDI药代理论) [3]

4.                              Kirkland, J. L., & Tchkonia, T. (2020). Senolytic drugs: From discovery to translation. Journal of Internal Medicine, 288(5), 518-536. (槲皮素作为Senolytic清除衰老细胞的医学依据) [4]

5.                              Auyeung, K. K., Han, Q. B., & Ko, J. K. (2016). Astragalus membranaceus: A review of its protection against inflammation and gastrointestinal cancers. The American Journal of Chinese Medicine, 44(01), 1-22. (黄芪甲苷与多糖的现代药理学综述) [5]

6.                              Szewczyk, K., & Miazga-Karska, M. (2021). Panax quinquefolius L. (American Ginseng) as an adaptogen: A review of its chemistry and pharmacology. Nutrients, 13(11), 4056. (西洋参适应原及糖代谢调节临床数据) [6]

7.                              Zhang, Y., & Wang, D. (2018). Ganoderma lucidum (Reishi mushroom) triterpenoids and polysaccharides: Inhibiting neuroinflammation in Alzheimer’s disease models. International Journal of Molecular Sciences, 19(11), 3542. (灵芝成分抑制小胶质细胞NF-κB通路研究) [7]

8.                              Sano, T., & Williamson, E. M. (2019). Cardiovascular benefits of grape seed proanthocyanidins: Mechanisms of endothelial nitric oxide synthase (eNOS) activation. Phytomedicine, 56, 122-130. (葡萄籽提取物促一氧化氮释放与内皮保护机制) [8]

9.                              Tarirai, C., & Viljoen, A. M. (2010). Herb-drug interactions: The impact of flavonoids and polyphenols on CYP3A4 and P-glycoprotein. Journal of Ethnopharmacology, 128(2), 263-281. (槲皮素和多酚对他汀类药物CYP3A4代谢干扰的研究) [9]

10.                         Yuan, C. S., & Wang, C. Z. (2004). Brief communication: American ginseng reduces the anticoagulant effect of warfarin in a randomized trial. Annals of Internal Medicine, 141(1), 23-27. (西洋参引发华法林抗凝失效的经典RCT临床文献) [10]

中文文献(国内核心期刊及经典医著)

11.                          张铁军, 刘昌孝. (2016). 中药质量标志物(Q-Marker)研究: 提高中药有效性与安全性的现代植物化学方法. 中草药, 47(1), 1-9. (支持第四章HPLC与质量标志物分析理论) [11]

12.                          王永炎, 鲁兆麟. (2008). 《黄帝内经》老龄医学思想与中医“治未病”在现代慢病管理中的价值. 中医杂志, 49(3), 197-200. (支持第二章中医老年生理及治未病理论) [12]

13.                          李晓东, 陈可冀. (2019). 活血化瘀中药与抗血小板西药联合应用的出血风险及临床风控对策. 中国中西医结合杂志, 39(8), 912-915. (支持第五章阿司匹林与丹参/三七等合用的药效学冲突风控) [13]

14.                          国家药典委员会. (2025). 《中华人民共和国药典》(2025年版). 北京: 中国医药科技出版社. (中草药基原、炮制、性味归经与配伍禁忌的国家法定标准) [14]

15.                          刘建平. (2015). 传统草药在现代老年医学中的循证临床研究方法学探讨. 中国循证医学杂志, 15(4), 481-486. (支持第四章中西草药随机对照试验RCT及系统评价的循证医学方法) [15]